UNI-ASIA Logo WATA Logo
Zhang Junxi
Appointment
Zhang Junxi
Associate Chief PhysicianVice President of the Zigong Campus of Huanya Hospital (Zigong High-Tech Oncology Hospital) and Director of Ward I
20+ years of clinical experience in oncology treatment
20,000+ cumulative surgical and interventional procedures
Invited multiple times to attend China’s leading academic conferences
Specialties:
Proficient in the full range of tumor ablation techniques, including chemical ablation, radiofrequency ablation, microwave ablation, argon-helium cryoablation, and NanoKnife ablation. He specializes in intravascular and non-vascular interventional treatment for solid tumors such as liver cancer, lung cancer, and pancreatic cancer.
Academic Positions
Member of the Chinese Society of Clinical Oncology (CSCO)
Member of the First Committee of the Palliative Care Professional Committee, Sichuan Medical Doctor Association
Member of the Targeted Therapy Professional Committee, Sichuan Cancer Society
Young Member of the Oncology Professional Committee, Sichuan Society of Rehabilitation Medicine
Member of the Interventional Therapy Professional Committee, Chengdu High-Tech Medical Association
Expert Member of the Zigong Peripheral Intervention Quality Control Center Member of the Zigong Oncology Quality Control Center

Safeguarding the Hope of Life Through Minimally Invasive Techniques, and Interpreting the Original Aspiration of a Physician Through Twenty Years of Dedication

—A Conversation with Dr. Zhang Junxi, Vice President of the Zigong Campus of Huanya Hospital (Zigong High-Tech Oncology Hospital)

Two Decades Dedicated to Minimally Invasive Interventional Oncology, Continuing the Life Stories of Cancer Patients with Millimeter-Level Precision

At the clinical forefront of minimally invasive interventional oncology, there is a physician who uses slender puncture needles and catheters as his instruments. Under the precise guidance of CT and DSA, he reaches directly into the core of lesions, delivering ablation energy and chemotherapy drugs accurately to tumor areas. Rooted in frontline clinical practice for nearly twenty years, he has performed thousands of interventional procedures, bringing the concepts and techniques of China’s leading interventional centers to clinical practice and rekindling hope for countless patients with advanced tumors facing desperate situations. He is Dr. Zhang Junxi, Vice President of the Zigong Campus of Huanya Hospital (Zigong High-Tech Oncology Hospital), Director of Ward I, Associate Chief Physician, and member of the Chinese Society of Clinical Oncology (CSCO).

Dr. Zhang Junxi pursued advanced training in the Department of Interventional Medicine at West China Hospital of Sichuan University and at Henan Provincial People’s Hospital, absorbing the advanced concepts and technical essence of China’s top interventional centers in intravascular and non-vascular tumor intervention. Since then, he has focused on minimally invasive interventional oncology for twenty years, providing individualized comprehensive treatment for tumor patients from around the world with superb technical skill and compassion.

In the field of minimally invasive intervention, Dr. Zhang Junxi is proficient in the full range of tumor ablation techniques, including chemical ablation, radiofrequency ablation, microwave ablation, argon-helium cryoablation, and NanoKnife ablation. He is especially skilled in intravascular and non-vascular interventional treatment for solid tumors such as liver cancer, lung cancer, and pancreatic cancer. In the field of respiratory intervention, he is skilled in EBUS-TBNA puncture technology, providing an important basis for the accurate diagnosis and staging of lung cancer. He advocates the comprehensive oncology treatment concept of“equal emphasis on local and systemic therapy”and is adept at integrating chemotherapy, molecular targeted therapy, biotherapy, immunotherapy, and other modalities to tailor individualized treatment plans for each patient.

In 2023, he was elected as a member of the First Committee of the Palliative Care Professional Committee of the Sichuan Medical Doctor Association. Since then, he has paid greater attention to symptom control and quality of life for patients with end-stage tumors, and has been committed to integrating the concept of palliative care into every stage of comprehensive oncology management. From curative ablation for solid tumors to palliative symptom relief for advanced-stage patients, from precise image-guided puncture to individualized comprehensive treatment decisions, Dr. Zhang Junxi has interpreted the responsibility and commitment of an interventional oncologist through nearly twenty years of dedication.

Patient stories
At UNI-ASIA Cancer Hospital, every journey in search of care is marked by courage and hope, and every story bears witness to doctors and patients working together to overcome disease.
More Cases
Patient Lao Chen
Bladder Cancer
China
Patient Lao Chen
A Chinese patient diagnosed with invasive urothelial carcinoma of the bladder experienced repeated postoperative recurrence and multiple metastases. After undergoing several open surgeries and chemotherapy regimens, the patient's condition became physically intolerable. At the end of 2024, the patient was transferred to Chengdu Uni-Asia Hospital, where Professor Liao Zhengyin's team performed CT combined with ultrasound-guided cryoablation of the abdominal wall metastatic lesion. The patient was able to get out of bed and move around the day after the procedure, was discharged smoothly after only five days of hospitalization, and regained a peaceful life.
Ms. Nguyen
Lung Cancer
Vietnam
Ms. Nguyen
A Vietnamese patient, 68 years old, was diagnosed with small-cell neuroendocrine carcinoma of the right lung with metastases in both lungs. She had previously undergone partial resection of the right lung and multiple rounds of chemoradiotherapy. After recurrence and metastasis left her without the option of surgery, she was referred to Chengdu Uni-Asia Hospital by an international referral center. Professor Liao Zhengyin's team performed minimally invasive interventional chemoembolization for her. She was able to get out of bed and move around the day after the procedure; her cough and shortness of breath improved significantly, and she was discharged smoothly a few days later to return home, regaining a normal life.
Catia
Liver Cancer
Philippines
Catia
A 42-year-old Filipino patient was diagnosed with primary liver cancer with intrahepatic metastases and a tumor thrombus in the inferior vena cava (stage IV), and had lost the opportunity for surgical resection. He was referred to Chengdu Uni-Asia Hospital through an international referral center. Professor Luo Xiaoping’s team first performed biliary drainage to relieve jaundice, and after his condition stabilized, carried out hepatic arterial infusion chemotherapy and embolization to control the tumor. After the procedure, his abdominal distension was significantly relieved; he was able to get out of bed the next day and was successfully discharged to return home.
Patient Akun
Liver Cancer
China
Patient Akun
A Chinese patient was diagnosed with liver cancer accompanied by metastasis to the C3 cervical vertebra and a pathological fracture. On admission, he had severe neck pain and markedly limited movement. The Uni-Asia team first performed cervical vertebroplasty to stabilize the vertebra and relieve pain, and on the following day performed transarterial chemoembolization of the hepatic artery to control the intrahepatic tumor. After surgery, his pain was significantly relieved; he was able to get out of his wheelchair and walk, and he was in good spirits at discharge.

Consultation

Consultation Type
Name
Gender
Date of Birth
Nationality
Country of Residence
Phone Number
Email
Your Question
Privacy Policy and Statement

Submitted Successfully

We have received your consultation. Thank you for your trust. A specialist will contact you within 72 hours, so please keep an eye on your phone calls and email.